sars-cov-2

Documents about sars-cov-2

• Vienna Versus SARS-CoV-2 Virus Study#875352ClinicalTrials.gov
• Hybrid SARS-CoV-2 immunity among frontline workers in a high-tourism setting: A community-based serosurvey in Ambergris Caye, Belize, June 2022#172210PLOS
• A CRISPR/Cas12 trans-cleavage reporter enabling label-free colorimetric detection of SARS-CoV-2 and its variants#342281KOASAS: KAIST Open Access Self-Archiving System
• COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities#831341ClinicalTrials.gov
• Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity#346978ClinicalTrials.gov
• Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers#444754ClinicalTrials.gov
• Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2#813186ClinicalTrials.gov
• CovidSurg-3: Outcomes of Surgery in COVID-19 Infection#862472ClinicalTrials.gov
• REassessement After Hospitalization for Sars-COV-2 disordER#444823ClinicalTrials.gov
• CoV-ICU Score, Intensive Care Unit, SARS-CoV-2#859368ClinicalTrials.gov
• SARS-CoV-2 Variants of Concern Pathogenesis and Prevention#492167ScholarWorks@GSU
• Editorial: Deciphering the T cell response in SARS-CoV-2 infection#250590IRIS
• Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants#261365ClinicalTrials.gov
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age#290843ClinicalTrials.gov
• Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall#812143ClinicalTrials.gov
• The Canadian Respiratory Research Network Long COVID-19 Study#852880ClinicalTrials.gov
• Persistent symptoms, cognitive impairment, and clinical predictors of long COVID one year after Omicron infection: A clinical case–control study from the Faroe Islands#285433PLOS
• Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa#828202ClinicalTrials.gov
• Tracking the evolution of biomarker efficacy in SARS-CoV-2: a global meta-analyses series#325041Apollo
• Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19#353333ClinicalTrials.gov
• Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities#829633ClinicalTrials.gov
• Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative#292676PLOS
• Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19#849631ClinicalTrials.gov
• A educação em saúde na escola nos cenários da pandemia pelo Sars-Cov-2 no estado do Amazonas#226407Dialnet
• Addressing gaps in surveillance: Use of emergency department accessibility and social vulnerability to identify potential wastewater surveillance sites in North Carolina#461605PLOS
• UNDERSTANDING IMMUNE DYNAMICS IN SARS-COV-2 RE-INFECTION AND VIRAL REACTIVATION#15721DataCite
• UNDERSTANDING IMMUNE DYNAMICS IN SARS-COV-2 RE-INFECTION AND VIRAL REACTIVATION#15722DataCite
• A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)#343699ClinicalTrials.gov
• Unvealing newly discovered small molecules as ACE2-spike inhibitors against SARS-CoV-2.#644266IRIS
• Registry of Sustained Immunity to COVID-19 Among ESKD Patients#862423ClinicalTrials.gov
• Lactoferrin for Prevention of COVID-19 in Health Care Workers#878482ClinicalTrials.gov
• The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2.#275606NCBI PubMed Central
• Electrocardiogram Analysis in COVID-19 Patients#803582ClinicalTrials.gov
• A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections#874191ClinicalTrials.gov
• Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: A retrospective cohort study from Alberta, Canada#461601PLOS
• Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)#174933ClinicalTrials.gov
• Detection of SARS-CoV-2 in various clinical specimens using PCR#260340Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects#805923ClinicalTrials.gov
• Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction#834149ClinicalTrials.gov
• SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings#867121ClinicalTrials.gov
• Respiratory Aerosols in Patients With COVID-19 and Healthy Controls#881579ClinicalTrials.gov
• COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations#311168ClinicalTrials.gov
• Complex intervention programme to improve patient safety and facilitate deprescribing in frail older patients living at home (COFRAIL): A process evaluation of a cluster randomised controlled trial#351911PLOS
• Wastewater SARS-CoV-2 RNA level and COVID-19 cases for 11 Alberta sites during May 10, 2020, to March 15, 2022#387038Borealis Dataverse OAI Archive
• DNA oligonucleotides block viral entry of SARS-CoV-2 Omicron variants#416083PLOS
• Immunodiagnostic performance and functional characterization of SARS-CoV-2-derived synthetic peptide-based antigenic constructs (SPACs)#632334Thesis Commons
• Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England#648492Spiral
• COVID-19 (SARS-CoV-2) in Urine and Semen#800974ClinicalTrials.gov
• Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)#828255ClinicalTrials.gov
• A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19#838001ClinicalTrials.gov